Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), and Civica, Inc. (Civica), a not-for-profit generic drug and ...
AstraZeneca to bring innovative medicines faster to India, says MD Panchal
The company reported a robust set of numbers for the December quarter of FY25, with its profit nearly doubling year-on-year ...